EZH2 Inhibitors
| Cat. No. | Product Name / Activity |
|---|---|
| 4703 | 3-Deazaneplanocin A hydrochloride |
| EZH2 histone methyltransferase inhibitor | |
| 6790 | GSK 126 |
| Very high affinity and selective EZH2 inhibitor | |
| 6128 | GSK 343 |
| Potent and selective SAM-competitive EZH2 inhibitor | |
| 6153 | JQEZ5 |
| Potent and selective SAM-competitive EZH2 inhibitor | |
| 6169 | PF 06726304 acetate |
| Highly potent and SAM-competitive EZH2 inhibitor | |
| 8093 | Tazemetostat |
| Potent and selective EZH2 inhibitor | |
| 4904 | UNC 1999 |
| Potent and selective EZH2/EZH1 inhibitor |
Our Epigenetics review gives an overview of the development of chemical probes for epigenetic targets, and discusses their biological effects.
Request copyRequest PDF
Our Stem Cells review gives an overview of the use of small molecules in the control of stem cell growth & differentiation and somatic cell reprogramming.
Request copyRequest PDFTaken from the Cancer Product Guide Edition 3
Our Cancer Metabolism poster summarizes the main metabolic pathways in cancer cells, and highlights potential targets for cancer therapeutics.
Request copyDownload PDFTaken from the Cancer Product Guide Edition 3
Our Epigenetics in Cancer poster summarizes the main epigenetic targets in cancer, and highlights chemical compounds for the inhibition of these targets.
Request copyDownload PDF
Written by Rebecca Quelch and Stefan Przyborski, this poster summarizes the isolation of pluripotent stem cells, their maintenance in culture, differentiation, and potential uses.
Download PDF